Alcon Inc. Ordinary Shares (ALC) is a publicly traded Healthcare sector company. As of May 21, 2026, ALC trades at $67.53 with a market cap of $32.17B and a P/E ratio of -38.66. ALC moved +1.45% today. Year to date, ALC is -16.58%; over the trailing twelve months it is -23.61%. Its 52-week range spans $61.84 to $100.71. Analyst consensus is buy with an average price target of $91.55. Rallies surfaces ALC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Alcon Shares Plunge 12% to 52-Week Low Despite 10% Q1 Revenue Gain: Stifel Nicolaus lowered its price target on Alcon to $70, implying a 6.88% upside from current $65.50, despite a 12.14% share plunge to a 52-week low of $64.75. The company posted Q1 revenue of $2.70 billion, up 10%, and core diluted EPS of $0.85.
| Metric | Value |
|---|---|
| Price | $67.53 |
| Market Cap | $32.17B |
| P/E Ratio | -38.66 |
| EPS | $-1.74 |
| Dividend Yield | 0.28% |
| 52-Week High | $100.71 |
| 52-Week Low | $61.84 |
| Volume | 2.77M |
| Avg Volume | 0 |
| Revenue (TTM) | $224.23M |
| Net Income | $-39.99M |
| Gross Margin | 0.00% |
16 analysts cover ALC: 0 strong buy, 11 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $91.55.